Updates

InnovaDerma

June 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

The shares spiked wildly after InnovaDerma announced it has launched Prolong, the world’s only FDA cleared medical device for premature ejaculation in the US and Australia. The launch is supported by a highly creative marketing campaign including a website, smilingdick.com, a new sex-positive platform aiming to destigmatise discussions around sexual health and wellbeing for men. InnovaDerma conducted in-depth research with 4,000 men and women across Australia and the US to aid the launch and one interesting fact is that as many as one in two men in the US and one in three in Australia claim to suffer from premature ejaculation. InnovaDerma is also seeking CED mark of regulatory approval for Prolong in order to launch into UK and Eu ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Applegreen

Tritax Big Box

InnovaDerma (April 2018)

InnovaDerma - Exciting personal and medical devices business (March 2018)

Innovaderma - Gain in two months: 64% (August 2017)

Innovaderma - Skinny Tan owner growing at a spectacular rate (June 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X